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Alzheimer’s disease (AD) is one of the most widespread neurodegenerative disea-
ses that involve dementia and mainly afflict people over 65 years of age. The therapy of
early and moderate stages of AD is mainly based on acetylcholine esterase inhibitors
such as synthetic donepezil and galanthamine isolated from the bulbs of daffodils. How-
ever, these licensed medicines have drawbacks of inducing severe peripheral and central
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Acetylcholinesterase (AChE) inhibitors are widely used
for the symptomatic treatment of Alzheimer’s disease
(AD) to enhance central cholinergic transmission. On the
other hand, butyrylcholinesterase (BuChE) inhibitors
were reported to produce a significant increase in brain
extracellular AChE without triggering severe peripheral
or central side effects. In the present study, we selected
twelve plants used in traditional European medicine to
treat different central nervous system (CNS) disorders or
to improve memory.
Methanolic and hexane extracts of these plants were tes-
ted for the AChE and BuChE inhibitory activity using Ell-
man’s colorimetric method. The most potent AChE and
BuChE inhibition was observed in the hexane extracts of
the flowers of Arnica chamissonis Less. subs. foliosa and
Ruta graveolens L. herb at a concentration of 400 mg mL–1.
However, methanolic extracts of the flowers of Arnica
chamissonis Less. subs. foliosa and the Hypericum per-
foratum L. herb demonstrated at the same concentration,
selective inhibition only against AChE but not against
BuChE. The other extracts did not show any significant
AChE or BuChE inhibitory activity. Our results show that
further investigations of the extracts of arnica, rue and
St. John’s Wort are needed to identity the compounds re-
sponsible for the AChE and BuChE inhibitory activity.
Keywords: acetylcholinesterase inhibition, butyrylcholin-
esterase inhibition, traditional medicine
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side effects, including gastrointestinal disturbances, insomnia, fatigue or depression. On
the other hand, since the BuChE activity in AD increases progressively as the severity of
dementia progresses, researchers have investigated selective BuChE inhibitors in the
treatment of AD as well (1). The serious side effects caused by licensed drugs used to
treat AD have forced researchers to investigate safer AChE- or BuChE inhibitors from
natural sources.
One of the best sources of new substances to treat AD are natural products and their
derivatives. Traditionally, plants have been used to enhance memory and to alleviate
other symptoms associated with AD (2). The biologically active plant-derived substan-
ces that may be considered as a source of new anticholinesterase drugs come from dif-
ferent classes of compounds and are characterized by the diversity of their structures.
The majority of bioactive substances are indole-, steroidal-, piperidine- and Amaryllida-
ceae alkaloids, phenylpropanoids (furanocoumarins, xantones, and flavonoids) and ter-
penoids (diterpenes) (2).
The aim of this study was to investigate possible AChE or BuChE inhibitors in plants
traditionally used in European medicine and to point to the role of these plants as poten-
tial sources for the development of therapeutic agents of AD. Selection of the species
screened in this study was based on their use as remedies for the central nervous system
diseases, as antidotes for plant and animal poisoning or to enhance memory.
EXPERIMENTAL
Plant material and chemicals
Plants were collected from The Botanical Garden of the Polish Academy of Science.
A specimen of each raw material is available in the herb collection of the Department of
Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy, Medical
University of Warsaw, Poland. Each plant material was dried and ground in a grinder.
Plants and their parts used in this study are presented in Table I.
Electric eel AChE (type VI-S), horse-serum BuChE, acetylthiocholine iodide, buty-
rylthiocholine chloride, 5,5’-dithio-bis[2-nitrobenzoic acid], Tris-HCl [Tris(hydroxyme-
thyl)aminomethane hydrochloride], 1-naphtyl acetate, bovine serum albumin (BSA, al-
bumin fraction V from bovine serum), 3,3’-dimethoxybiphenyl-4,4’-di(diazonium) zinc
chloride (Fast Blue B salt), physostigmine salicylate, galanthamine hydrobromide, anis-
aldehyde were purchased from Sigma-Aldrich (USA). Methanol, toluene, ethyl acetate,
hexane and sulphuric acid were purchased from Chempur (Poland). All reagents used
in the study were of analytical grade.
Extract preparation
For extraction, 2 g of air-dried and powdered plant material was extracted over a
water bath at 60 °C in 40 mL of methanol or hexane under reflux for 30 min. The extrac-
tion was done in triplicate. The resulting liquid extract was filtered and concentrated to
dryness under reduced pressure at 60 °C. At 60 °C, the components in plant extracts were
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stable. The dry extracts were stored at 4 °C and dissolved in an appropriate solvent just
before the test.
Determination of enzyme activity
All extracts were tested for AChE and BuChE inhibitory activity at concentrations
of 100 and 400 mg mL–1 by the modified spectrophotometric method developed by Ell-
man (3). For herbal extracts that were proven to exert significant inhibition and for posi-
tive controls, dose-dependent inhibitory assays were performed. The plant extracts were
tested in a concentration range of 12.5 to 400 mg mL–1. Galanthamine hydrobromide and
physostigmine salicylate were used as AChE and BuChE positive controls. They were
tested in a concentration range between 0.01 and 100 mg mL–1.
The assay was performed in a 1.5-mL Eppendorf tube as follows: 1 mg of metha-
nolic extract was dissolved in 1 mL Tris-HCl (50 mmol L–1, pH 7.8). Hexane extract (1 mg)
was dissolved in 100 mL methanol and diluted to 1 mL with Tris-HCl (50 mmol L–1, pH
7.8). Positive controls, namely galanthamine and physostigmine, were dissolved in me-
thanol (1 mg mL–1).
To determine the AChE and BuChE inhibitory activity, the following reaction was
performed. An appropriate amount of extract or positive control and 40 mL of AChE
(0.45 U mL–1) or BuChE (0.45 U mL–1) was mixed and diluted to 1 mL with Tris-HCl. Af-
ter 30 min of incubation at 4 °C, the reaction was initiated by addition of 20 mL of
5,5’-dithio-bis[2-nitrobenzoic acid] (3 mmol L–1) and 20 mL of acetylthiocholine iodide or
butyrylthiocholine chloride, respectively (both 15 mmol L–1, dissolved in Tris-HCl). The
samples were incubated for another 20 min over a water bath at 37 °C and the reactivity
was terminated by addition of 20 mL physostigmine salicylate (0.1 mmol L–1 in metha-
nol). Absorbance of the produced yellow 5-thio-2-nitrobenzoate anion was measured at
a wavelength of 412 nm using a Shimadzu UV 160A (Japan) spectrophotometer. Tris-
-HCl buffer was used as a blank.
Thin layer chromatography (TLC) bioautographic assay
TLC bioautographic assay was performed as described by Marston et al. (4). Extract
of the Arnica chamissonis flowers, 20 mL (0.2 g of dried extract dissolved in 1 mL metha-
nol) was applied to a silica gel plate (Kieselgel G, F254, type 60, Merck, Germany) and
eluted with toluene/ethyl acetate (50:50, V/V). After drying, the plate was sprayed with
13 U mL–1 AChE (dissolved in 50 mmol–1 Tris-HCl with 0.1 % BSA, pH 7.8) and kept in a
water bath at 37 °C for 20 minutes. The chromatogram was dried until complete mobile
phase was removed. Finally, the plate was sprayed with 0.25 % 1-naphtyl acetate (dis-
solved in methanol) and 0.25 % Fast Blue B salt (dissolved in deionized water). After a
few minutes, a purple background appeared with white spots for AChE inhibiting com-
pounds.
TLC method
Methanolic and hexane extracts of Arnica chamissonis ssp. foliosa, 10 mL and 20 mL,
respectively (0.2 g of dried extract dissolved in 1 of solvent) were applied to the silica gel
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plate (Kieselgel G, F254, type 60, Merck) and eluted with toluene/ethyl acetate (50:50,
V/V). Visualization of sesquiterpene lactones was done by spraying with methanolic so-
lutions of 0.5 % anisaldehyde and 5 % sulphuric acid followed by heating at 105 °C for 5
minutes.
Date processing
The extent of the enzymatic reaction was calculated based on the following equa-
tion: E = 100 – [(T – C1/C0) ´ 100], where E is the activity of the enzyme. E value conveys
the effect of the plant extract or the positive control on AChE or BuChE enzyme activity
expressed as the percentage of the remaining activity in the presence of plant extract or
positive control, T (test) is the absorbance of the tested sample (plant extract or positive
control in the solvent) in the presence of enzyme, C1 (control 1) is the absorbance of the
tested sample (plant extract or positive control in the solvent) in the absence of enzyme,
C0 (control 0) is the absorbance of the solvent in the presence of enzyme.
Data are expressed as mean ± standard error (SEM) and the results were taken from
at least three independent experiments performed in duplicate.
Estimation of IC50 values
The IC50 values (concentration of test compounds that inhibits the hydrolysis of
substrates by 50 %) were determined by spectrophotometric measurement of the effect
of increasing concentrations of test compounds (plant extracts and positive controls) on
the AChE or BuChE activity. IC50 values were obtained from dose-effect curves by linear
regression.
RESULTS AND DISCUSSION
Screening of methanolic and hexane extracts showed that 4 out of 24 plant extracts
were able to inhibit the enzymatic activity of either AChE or BuChE or both. It was
found out that all the hexane and methanolic extracts had dose-dependent inhibitory ac-
tivity. Significant reduction in the activity of AChE was observed at the concentration of
400 mg mL–1 for Arnicae flos (hexane and methanolic extract), Rutae herba (hexane and
methanolic extract) and Hyperici herba (methanolic extract). The strongest BuChE inhibi-
tors that showed inhibition higher than 50 % at the concentration of 100 mg mL–1 were
found in hexane extracts of Rutae herba and Arnicae flos. The results on the effects of the
tested herbal extracts on AChE and BuChE activity are summarized in Table I. The
dose-dependent AChE inhibitory activity of these three herbs was further studied and
the IC50 values of inhibition are tabulated in Table II.
The most potent extract was the hexane extract of Arnica chamissonis with IC50 of
29 mg mL–1. At a concentration of 100 mg mL–1, it reduced the enzymatic activity of
AChE to 23.6 % and BuChE to 36.1 %. Methanolic extract of Arnica chamissonis caused
similar reduction of AChE activity at a concentration of 100 mg mL–1 (IC50 = 43 mg mL–1).
However, no BuChE inhibitory activity was found for the hexane extract of Arnica chami-
ssonis. The AChE inhibitory effect of these extracts was less potent than that of the refer-
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ences galanthamine (IC50 of galanthamine for AChE and BuChE was 0.14 and 3.13 mg L–1,
respectively) and physostigmine (IC50 of physostygmine for AChE and BuChE 0.064 and
0.54 mg L–1, respectively).
The components found in Arnica chamissonis include sesquiterpene lactones, flavo-
noids and essential oil with terpenes. Detailed chemical composition of the tested plant
parts is presented in Table III. Out of these compounds, terpenes like cineol, borneol,
geraniol, 3-carene, a-caryophyllene or limonene were previously found to express some
AChE or BuChE inhibitory activity (2, 5). However, no sesquiterpene lactones inhibitory
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Table II. Anti-AChE and BuChE activity of the most active plant extracts
Sample IC50 (AchE) (mg mL–1) IC50 (BuChE) (mg mL–1)
Arnicae flos (hexane extract) 29 88
Arnicae flos (methanolic extract) 43 –
Hyperici herba (methanolic extract) 178 –
Rutae herba (hexane extract) 34 61












IC50 values were obtained from the dose-effect curves by linear regression.
1 2 3 41 2 3 4
b)a)
Fig. 1. TLC of extracts of Arnica chamissonis Less. ssp. foliosa showing acetylcholinesterase inhibitory
activity: a) white spots indicate inhibition, arrows indicate the AChE inhibiting constituents, b) TLC
plate sprayed with methanolic solution of 0.5 % anisaldehyde and of 5 % sulphuric acid followed
by heating at 105 °C for 5 minutes. Black spots indicate the presence of sesquiterpene lactones; ar-
rows indicate the AChE inhibiting constituents. 1–4 are methanolic extract 10 mL, methanolic ex-
tract 20 mL, hexane extract 10 mL, hexane extract 20 mL, respectively.
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Table III. Detailed chemical composition of the tested plants (literature survey)













sesquiterpene lactones of pseudoguaianolide type
(0.2–1.5 %)-helenelin, flavonoids (0.4–0.6 %)-flavonols
and flavones, essential oil (0.15–0.28 %)-fatty acids,
sesquiterpenes, monoterpenes, caffeoylquinic acids-





phenylpropanoids (5.5 %)-verbascoside, forsythoside B,
arenarioside and ballotetroside, diterpenoids,





bitter sesquiterpene lactone ester cnicin (0.2–0.7 %);
other germacrane sesquiterpenes include salonitenolide
and artemisiifolin; the bitter lignans trachelogenin,
arctigenin, and nortracheloside are also present, essen-






coumarins (1.06 %)-coumarin, o-coumaric acid
glucoside; iridoids asperulosiode (0.28 %),





phloroglucinol derivatives (0.2–0.4 %), principally
hyperforin, adhyperforin, naphtodiantrones
(0.1–0.3 %)-hypericin (0.08 %), pseudohypericin,
flavonoids (2–4 %) include hyperoside, rutin,
isoquercitrin, biflavones and others, tannins-





essential oil (0.3–1 %)-mainly isopinocamphone,
limonene, b-pinene; flavonoids (5–6%)-principally
diosmin (3–6%), tanins (5–8%), phenylpropanoids
including rosmarinic acid, caffeic acid and






menthiafolin and loganin, monoterpenoid alkaloids












essential oil (0.2–0.4 %) with nonan-2-one, flavonoids
(2–5 %) – rutine, coumarins-furanocoumarines –
bergapten, psoralen, xanthoxanthin, xanthotoxin,
isopimpinellin and rutamarin, alkaloids (0.4–1.4 %) are







sesquiterpene lactones (0.2–1.8 %)-parthenolid,
eudesmenolide, guajanolide, flavanoids-apigenin, lu-
teolin, chrysoeriols derivatives, essential oil (0.2–0.7 %)
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activity against AChE was reported. Therefore, we performed a TLC- and TLC bioauto-
graphic assay to rule out this action.
The TLC bioautographic assay demonstrated that AChE inhibiting activity of Arnica
chamissonis was due to compounds which in the TLC bioautographic assay appeared as
white spots (Fig. 1). To determine whether the inhibition of AChE activity by arnica ex-
tracts was mediated by sesquiterpene lactones, TLC analysis was performed. The com-
pounds that reacted as dark purple-grey spots with anisaldehyde sulfuric acid reagent
indicated sesquiterpene lactone derivatives. The location of the white and dark spots on
the TLC plate presented in Fig. 1 implicated that the compounds reacting as AChE in-
hibitors were of sesquiterpene lactones origin. The presented findings have never been
reported earlier and we suggest that Arnica chamissonis should be considered for further
studies to isolate compounds responsible for the anti-AChE activity.
In the present study, the hexane extract of Rutae herba exhibited moderate AChE and
BuChE inhibitory activity with IC50 34 and 61 mg mL–1, respectively. Adsersen (6) found
AChE inhibitory activity of the methanolic extract of Ruta graveolens (100 mg mL–1),
which caused 39 % inhibition; on the other hand, no reports about the activity of Ruta
graveolens hexane extract against BuChE inhibition have been published. Compounds
present in rue that could be considered to have cholinergic activity included alkaloids
and furanocoumarins. It has been previously shown that alkaloids belonging to different
groups such as physostigmine, (–)-hupercin A or galanthamine (4) and some furanocou-
marines like isoimperatorin, xanthotoxin and marmesin exhibited AChE and BuChE in-
hibitory effects (7). Kang (7) suggested that coumarin skeleton contained a pyrone moi-
ety, which played an important role in the inhibitory activity against AChE. The pre-
sence of coumarines in Ruta could partly explain the anti-AChE activity of the hexane
rue extract proven in this study.
The lowest IC50 value was obtained with the methanolic extract of Hypericum perfo-
ratum herb. The methanolic extract was found to exhibit a weak inhibitory effect against
AChE compared to galathamine and physostigmine. It reduced AChE activity to 28 % at
a concentration of 400 mg mL–1 with IC50 of 178 mg mL–1. It was previously reported that
the ethanolic extract of another Hypericum species, namely Hypericum undulatum, inhib-
ited AChE activity by 69 % at 500 mg mL–1 (8). Pharmacological actions of the ethanolic
extract of Hypericum perforatum on CNS were well documented in previous reports (9).
The inhibiting AChE activity of this extract may belong to these biological actions.
The other tested plant extracts did not exhibit any significant AChE or BuChE in-
hibitory activity.
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iridoid glicosides – verbenalin (0.15 %), hastatoside
(0.08 %), dihydrocornine (0.01 %) and others,
hydroxycinnamic acid derivatives – verbascoside (0.8
%), isoverbascoside, martynosid, eukovoside,
flavanoids – flavone glycosides, especially luteolin





The present investigation has shown that hexane and/or methanolic extracts from
the flowers of Arnica chamissonis Less. ssp. foliosa, the herb Ruta graveolens L. and the
herb Hypericum perforatum L. could inhibit the activity of AChE or BuChE or both. AChE
inhibitory activity of Arnica extracts was among others, due to sequiterpene lactones.
The extracts of arnica, rue and St. John’s Wort were proved to have a great potential
and should be considered for further studies to identify the constituents responsible for
the AChE and BuChE inhibitory activity, which can be eventually utilized in the treat-
ment of AD.
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S A @ E T A K
Pretraivanje tradicionalnih europskih ljekovitih biljaka na inhibiciju
acetilkolinesteraze i butirilkolinesteraze
NATALIA WSZELAKI, AGNIESZKA KUCIUN i ANNA KAROLINA KISS
Inhibitori acetilkolinesteraze (AChE) pove}avaju kolinergi~ku transmisiju u mozgu,
pa se koriste za simptomatsko lije~enje Alzheimerove bolesti (AD). S druge strane, inhi-
bitori butirilkolinesteraze (BuChE) zna~ajno pove}avaju ekstracelularnu koli~inu AChE
u mozgu, a da pri tome ne uzrokuju snane nuspojave ni u središnjem ni i perifernom
iv~anom sustavu. Galantamin, jedan od odobrenih AChE inhibitora, alkaloid iz luko-
vica narcisa, pokazuje da su biljke zna~ajni izvor novih potencijalnih AChE- i BuChE-
inhibitora. U ovom radu, ispitivan je u~inak dvanaest biljaka koje se koriste u tradi-
cionalnoj europskoj medicini na razli~ite poreme}aje središnjeg iv~anog sustava i na
poboljšanje pam}enja. Pomo}u Ellmanove kolorimetrijske metode pra}en je inhibitorni
u~inak metanolnih i heksanskih ekstrakata tih biljaka na AChE i BuChE. Najja~i inhi-
bitorni u~inak pokazali su heksanski ekstrakti cvjetova Arnica chamissonis Less. susb. fo-
liosa i nadzemnih dijelova Ruta graveolens L. u koncentraciji od 400 mg mL-1. Me|utim,
metanolni ekstrakti cvjetova Arnica chamissonis Less. susb. foliosa i nadzemnih dijelova
Hypericum perforatum L. u istim koncentracijama pokazuju selektivnu inhibiciju samo na
AChE. Ostali ekstrakti bili su nedjelotvorni. Rezultati ukazuju na potrebu daljnjih ispi-
tivanja ekstrakata arnike, rute i gospine trave da se utvrdi koji su sastojci ekstrakata
odgovorni za inhibiciju AChE i BuChE.
Kljuène rijeèi: inhibicija acetilkolinesteraze, inhibicija butirilkolinesteraze, tradicionalna medicina
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